Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014.

scientific article

Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014. is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1044117263
P356DOI10.1038/NPJBCANCER.2015.2
P932PMC publication ID5515196
P698PubMed publication ID28721362
P5875ResearchGate publication ID277966891

P2093author name stringRamprasad Og Gopalan
Vidudala Vts Prasad
P2860cites workCharacterization of microRNA expression levels and their biological correlates in human cancer cell linesQ40158414
MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma researchQ40227151
Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.Q40464259
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell lineQ40554428
A systematic profile of DNA methylation in human cancer cell linesQ44342343
Rational combinations of siRNAs targeting Plk1 with breast cancer drugsQ79976833
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer modelsQ85657017
Design, synthesis and pharmacological screening of β-amino-, thiadiazole/thiadiazine-phosphonate based triazole motifs as antimicrobial/cytotoxic agentsQ85716742
Systematic variation in gene expression patterns in human cancer cell linesQ28145747
Human breast cancer cell lines co-express neuronal, epithelial, and melanocytic differentiation markers in vitro and in vivoQ28748502
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanomaQ29614282
Further evidence to support the melanocytic origin of MDA-MB-435Q30857872
Widespread intraspecies cross-contamination of human tumor cell lines arising at source.Q33875830
CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancerQ34176395
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophagesQ34975953
DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancerQ35121612
Inducing apoptosis effect of caffeic acid 3,4-dihydroxy-phenethyl ester on the breast cancer cellsQ35238861
Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasionQ35605887
Choosing the right cell line for breast cancer researchQ35608671
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasisQ36179588
MDA-MB-435: the questionable use of a melanoma cell line as a model for human breast cancer is ongoingQ36929337
Enhancement of taxol, doxorubicin and zoledronate anti-proliferation action on triple-negative breast cancer cells by a PTHrP blocking monoclonal antibodyQ37278425
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancerQ37624816
2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cellsQ38517006
Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.Q38967805
Evaluation of multimeric siRNA conjugates for efficient protamine-based delivery into breast cancer cellsQ39009675
MDA-MB-435 and M14 cell lines: identical but not M14 melanoma?Q39834203
EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cellsQ39880948
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 4.0 InternationalQ24082749
P6216copyright statuscopyrightedQ50423863
P921main subjectMDA-MB-435Q50952937
P304page(s)15002
P577publication date2015-06-02
P1433published inNPJ Breast CancerQ27727120
P1476titleContinued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014.
P478volume1

Reverse relations

cites work (P2860)
Q47644139Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.
Q26739912Cranberries and Cancer: An Update of Preclinical Studies Evaluating the Cancer Inhibitory Potential of Cranberry and Cranberry Derived Constituents
Q65976302Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems
Q37634520Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
Q37457902Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer
Q91943722Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells
Q42514809Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
Q89805585Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years
Q89174583Reagent Validation to Facilitate Experimental Reproducibility
Q58115302Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity
Q64081836Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date
Q60955162Store-Operated Ca Entry in Breast Cancer Cells: Remodeling and Functional Role

Q50952937MDA-MB-435described by sourceP1343

Search more.